Share This Link

Serum glucose levels are unrelated to the acute hematological disruption seen in placental abruption or the subsequent clotting cascade failure. While hyperglycemia may occur under general physiological stress, it provides no diagnostic value for detecting intravascular coagulation or maternal-fetal hemorrhage risk.

Liver function tests assess hepatic enzyme levels like aspartate aminotransferase and alanine aminotransferase, which are more relevant to preeclampsia syndromes like HELLP. While the liver synthesizes clotting factors, these tests do not track the acute consumption of fibrinogen or platelets during abruption.

Thyroid stimulating hormone panels evaluate endocrine function and the metabolic status of the thyroid gland rather than hematological stability. This laboratory assessment has no clinical utility in the emergency management of abruptio placentae or the detection of acute consumptive coagulopathy.

A nurse would expect a thrombocytopenia, or decreased platelet count, rather than an increase. Platelets are consumed in the formation of thousands of microscopic thrombi throughout the vasculature, leaving the systemic circulation depleted and unable to maintain primary hemostasis at injury sites.

The prothrombin time (PT) and activated partial thromboplastin time (aPTT) would be prolonged, not decreased. A decrease would imply a hypercoagulable state, whereas DIC causes a prolonged duration for clot formation due to the depletion of essential circulating coagulation factors and plasma proteins.

Hemoglobin and hematocrit typically decrease in the presence of systemic bleeding and retroplacental hemorrhage. An increase in these values would suggest hemoconcentration, but in acute abruptio placentae with DIC, hemodilution or frank blood loss leads to a rapid decline in red cell indices.

Discharging the client based solely on a negative ultrasound is dangerous and represents medical negligence. In the presence of severe abdominal pain at 32 weeks, the risk of fetal distress or maternal hemorrhage necessitates inpatient observation and continuous monitoring.

Repeating ultrasounds every 30 minutes is clinically inefficient and delays definitive management. Diagnostic focus should shift from imaging to hemodynamic assessment and electronic fetal monitoring, as retroplacental clots may never become clearly visible on a standard ultrasound.

Attributing severe abdominal pain to Braxton-Hicks contractions is a significant diagnostic error. Braxton-Hicks are typically painless and irregular, whereas the pain from abruption is constant, severe, and associated with uterine hypertonicity, regardless of what the imaging suggests.

Increased urine output is not expected in the setting of acute blood loss and pathological clotting. The nurse should instead anticipate oliguria (output < 30 mL/hour) as a result of decreased renal perfusion from hypovolemic shock or microthrombi obstructing the glomerular capillaries.

Maternal blood pressure typically decreases, not increases, as a result of hemorrhagic shock. Rapidly increasing blood pressure is a hallmark of preeclampsia, whereas placental abruption complicated by DIC leads to circulatory collapse and hypotension once compensatory mechanisms like peripheral vasoconstriction fail.

Sudden, bright red, and painless vaginal bleeding is the classic presentation of placenta previa, not abruptio placentae. Abruption usually causes painful bleeding or concealed hemorrhage with uterine rigidity, and the development of DIC suggests a more severe, systemic disruption of the coagulation profile.